OrbiMed’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,024,000
Closed -$17.3M 120
2024
Q3
$17.3M Buy
11,024,000
+5,177,900
+89% +$8.13M 0.31% 69
2024
Q2
$9.82M Buy
5,846,100
+2,304,100
+65% +$3.87M 0.19% 74
2024
Q1
$8.5M Buy
+3,542,000
New +$8.5M 0.16% 85